Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Research Council grant · Running

PathsToDormancy PathsToDormancy: Identifying dormancy pathways for selective targeting

Coordinator
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eV, Germany
Runs
1 May 2025 to 31 October 2026
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101213404

What the project is doing

In the project's own words, from its summary on CORDIS.

The survival and propagation of species fundamentally depend on the precise regulation of cellular growth and dormancy. This balance is crucial across various biological processes including reproduction, regeneration, and repair, where mechanisms such as embryonic diapause allow organisms to endure adverse conditions by temporarily halting development. During this dormant state, embryonic cells undergo significant rewiring of their transcriptional, epigenetic, and metabolic pathways, preserving their stem cell characteristics and enabling reactivation under more favorable conditions.

Despite its essential role, dormancy presents challenges in cancer treatment. Cancer cells exploit conserved dormancy pathways to evade therapies, resulting in drug-tolerant persister (DTP) cells that can survive treatment, potentially leading to relapse with more aggressive and metastatic tumors. This phenomenon undermines efforts to combat cancer, as detecting and targeting dormant cancer cells remains a significant obstacle.

Here we will leverage our in vitro dormancy culture systems identify regulators of cancer dormancy with embryonic origin.

Topics

Who is involved

OrganisationCityCountryRole
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eVMunchenGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI